Guinness Atkinson Asset Management’s AbbVie ABBV Stock Holding History

Guinness Atkinson Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Sell	5,045 -381	-7%	-$82K	0.57%	31
2026 Q1	$1.18M	Sell	5,426 -345	-6%	-$76.5K	0.59%	30
2025 Q4	$1.33M	Sell	5,771 -129	-2%	-$29.4K	0.63%	30
2025 Q3	$1.32M	Hold	5,900	–	–	0.63%	30
2025 Q2	$1.1M	Hold	5,900	–	–	0.57%	37
2025 Q1	$1.24M	Sell	5,900 -904	-13%	-$176K	0.69%	28
2024 Q4	$1.21M	Buy	6,804 +1,287	+23%	+$237K	0.62%	30
2024 Q3	$1.09M	Sell	5,517 -198	-3%	-$37K	0.53%	32
2024 Q2	$980K	Sell	5,715 -99	-2%	-$16.4K	0.48%	33
2024 Q1	$1.06M	Hold	5,814	–	–	0.5%	37
2023 Q4	$901K	Sell	5,814 -170	-3%	-$24.8K	0.46%	39
2023 Q3	$892K	Buy	5,984 +408	+7%	+$59.9K	0.5%	39
2023 Q2	$751K	Buy	5,576 +1,839	+49%	+$270K	0.4%	54
2023 Q1	$596K	Buy	3,737 +80	+2%	+$12.2K	0.34%	55
2022 Q4	$591K	Sell	3,657 -304	-8%	-$46.6K	0.37%	56
2022 Q3	$532K	Sell	3,961 -1,832	-32%	-$263K	0.34%	62
2022 Q2	$887K	Hold	5,793	–	–	0.52%	41
2022 Q1	$939K	Hold	5,793	–	–	0.45%	40
2021 Q4	$784K	Sell	5,793 -381	-6%	-$45K	0.34%	42
2021 Q3	$666K	Sell	6,174 -508	-8%	-$58K	0.31%	49
2021 Q2	$753K	Buy	6,682 +382	+6%	+$43K	0.33%	42
2021 Q1	$682K	Buy	6,300 +200	+3%	+$21.4K	0.34%	40
2020 Q4	$654K	Buy	6,100 +882	+17%	+$84.8K	0.35%	39
2020 Q3	$457K	Buy	5,218 +700	+15%	+$65.9K	0.28%	47
2020 Q2	$444K	Hold	4,518	–	–	0.29%	34
2020 Q1	$344K	Buy	4,518 +390	+9%	+$33.2K	0.27%	34
2019 Q4	$365K	Hold	4,128	–	–	0.26%	49
2019 Q3	$313K	Hold	4,128	–	–	0.25%	47
2019 Q2	$300K	Buy	4,128 +758	+22%	+$59.6K	0.22%	56
2019 Q1	$272K	Buy	3,370 +650	+24%	+$53.2K	0.2%	47
2018 Q4	$251K	Hold	2,720	–	–	0.21%	47
2018 Q3	$257K	Hold	2,720	–	–	0.16%	60
2018 Q2	$252K	Hold	2,720	–	–	0.14%	55
2018 Q1	$257K	Hold	2,720	–	–	0.16%	54
2017 Q4	$263K	Sell	2,720 -760	-22%	-$71.6K	0.16%	54
2017 Q3	$309K	Hold	3,480	–	–	0.19%	47
2017 Q2	$252K	Hold	3,480	–	–	0.16%	49
2017 Q1	$227K	Hold	3,480	–	–	0.15%	54
2016 Q4	$218K	Sell	3,480 -660	-16%	-$40.3K	0.15%	53
2016 Q3	$261K	Hold	4,140	–	–	0.16%	58
2016 Q2	$256K	Sell	4,140 -650	-14%	-$39.6K	0.16%	58
2016 Q1	$274K	Hold	4,790	–	–	0.17%	68
2015 Q4	$284K	Hold	4,790	–	–	0.16%	67
2015 Q3	$261K	Hold	4,790	–	–	0.17%	61
2015 Q2	$322K	Hold	4,790	–	–	0.15%	58
2015 Q1	$280K	Buy	4,790 +1,860	+63%	+$112K	0.13%	66
2014 Q4	$192K	Hold	2,930	–	–	0.11%	57
2014 Q3	$169K	Buy	2,930 +560	+24%	+$31.1K	0.1%	61
2014 Q2	$134K	Buy	2,370 +400	+20%	+$21K	0.1%	64
2014 Q1	$101K	Buy	1,970 +600	+44%	+$30.3K	0.1%	63
2013 Q4	$72K	Hold	1,370	–	–	0.07%	63
2013 Q3	$61K	Hold	1,370	–	–	0.06%	66
2013 Q2	$57K	Buy	+1,370	New	+$59.9K	0.06%	72

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Guinness Atkinson Asset Management's ABBV Position: Q2 2026 in Review

Guinness Atkinson Asset Management reduced its AbbVie (ABBV) stake by 7% in Q2 2026, selling an estimated $82K and leaving 5,045 shares worth $1.27M. The position accounts for 0.57% of the portfolio, ranked #31.

Guinness Atkinson Asset Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.33M in Q4 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Guinness Atkinson Asset Management held 5,045 shares of AbbVie worth $1.27M as of Q2 2026.
Guinness Atkinson Asset Management sold 381 AbbVie shares in Q2 2026, an estimated $82K.
AbbVie made up 0.57% of Guinness Atkinson Asset Management's portfolio in Q2 2026, its #31 holding.
Guinness Atkinson Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Guinness Atkinson Asset Management's AbbVie position peaked at $1.33M in Q4 2025.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Guinness Atkinson Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.